3SPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
3SPHARMA
Largest movements
- Cash +€84,613
up €84,613 (+43.0%), from €196,786 to €281,399
mainly Net result for the year (+€74,387) and Depreciation (+€45,801)
- Intangible fixed assets -€29,000
down €29,000 (-20.0%), from €145,000 to €116,000
- Current investments -€25,000
down €25,000 (-50.0%), from €50,000 to €25,000
- Stocks and contracts +€22,938
up €22,938 (+16.9%), from €135,434 to €158,372
- Tangible fixed assets -€16,801
down €16,801 (-20.8%), from €80,673 to €63,872
of which Plant, machinery and equipment: -€14,661
- Reserves +€74,387
up €74,387 (+28.3%), from €263,150 to €337,537
of which Distributable reserves: +€74,387
- Debts after one year -€45,608
down €45,608 (-23.1%), from €197,393 to €151,785
- Gross operating margin +€32,039
up €32,039 (+18.7%), from €171,685 to €203,724
- Staff costs +€17,573
up €17,573 (+56.4%), from €31,174 to €48,747
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €653,285 | €683,783 | +€30,498 | +4.7% |
| Fixed assets | 21/28 | €225,738 | €179,937 | -€45,801 | -20.3% |
| Intangible fixed assets | 21 | €145,000 | €116,000 | -€29,000 | -20.0% |
| Tangible fixed assets | 22/27 | €80,673 | €63,872 | -€16,801 | -20.8% |
| Plant, machinery and equipment | 23 | €73,133 | €58,473 | -€14,661 | -20.0% |
| Furniture and vehicles | 24 | €4,159 | €2,391 | -€1,768 | -42.5% |
| Other tangible fixed assets | 26 | €3,380 | €3,008 | -€373 | -11.0% |
| Financial fixed assets | 28 | €65 | €65 | = | 0.0% |
| Current assets | 29/58 | €427,548 | €503,847 | +€76,299 | +17.8% |
| Stocks and contracts in progress | 3 | €135,434 | €158,372 | +€22,938 | +16.9% |
| Stocks | 30/36 | €135,434 | €158,372 | +€22,938 | +16.9% |
| Amounts receivable within one year | 40/41 | €20,345 | €18,373 | -€1,972 | -9.7% |
| Trade receivables | 40 | €7,517 | €12,950 | +€5,433 | +72.3% |
| Other amounts receivable | 41 | €12,828 | €5,424 | -€7,405 | -57.7% |
| Current investments | 50/53 | €50,000 | €25,000 | -€25,000 | -50.0% |
| Cash at bank and in hand | 54/58 | €196,786 | €281,399 | +€84,613 | +43.0% |
| Deferred charges and accrued income | 490/1 | €24,982 | €20,703 | -€4,280 | -17.1% |
| Total equity and liabilities | 10/49 | €653,285 | €683,783 | +€30,498 | +4.7% |
| Equity | 10/15 | €288,388 | €362,775 | +€74,387 | +25.8% |
| Contributions | 10/11 | €20,460 | €20,460 | = | 0.0% |
| Reserves | 13 | €263,150 | €337,537 | +€74,387 | +28.3% |
| Tax-exempt reserves | 132 | €471 | €471 | = | 0.0% |
| Distributable reserves | 133 | €262,678 | €337,065 | +€74,387 | +28.3% |
| Profit (loss) carried forward | 14 | €4,779 | €4,779 | = | 0.0% |
| Amounts payable | 17/49 | €364,897 | €321,008 | -€43,889 | -12.0% |
| Amounts payable after more than one year | 17 | €197,393 | €151,785 | -€45,608 | -23.1% |
| Financial debts | 170/4 | €197,393 | €151,785 | -€45,608 | -23.1% |
| Amounts payable within one year | 42/48 | €167,504 | €169,055 | +€1,551 | +0.9% |
| Current portion of amounts payable after more than one year | 42 | €47,097 | €45,608 | -€1,489 | -3.2% |
| Trade debts | 44 | €57,007 | €54,895 | -€2,112 | -3.7% |
| Suppliers | 440/4 | €57,007 | €54,895 | -€2,112 | -3.7% |
| Taxes, remuneration and social security | 45 | €18,647 | €23,899 | +€5,252 | +28.2% |
| Taxes | 450/3 | €9,744 | €10,210 | +€466 | +4.8% |
| Remuneration and social security | 454/9 | €8,903 | €13,690 | +€4,786 | +53.8% |
| Other amounts payable | 47/48 | €44,753 | €44,653 | -€100 | -0.2% |
| Accrued charges and deferred income | 492/3 | - | €168 | +€168 | |
| Non-recurring operating income | 76A | - | €6,934 | +€6,934 | |
| Remuneration, social security and pensions | 62 | €31,174 | €48,747 | +€17,573 | +56.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €47,743 | €45,801 | -€1,942 | -4.1% |
| Other operating charges | 640/8 | €1,019 | €953 | -€66 | -6.5% |
| Gross operating margin | 9900 | €171,685 | €203,724 | +€32,039 | +18.7% |
| Operating profit (loss) | 9901 | €91,749 | €108,223 | +€16,474 | +18.0% |
| Financial income | 75/76B | €108 | €1,080 | +€972 | +896.2% |
| Recurring financial income | 75 | €108 | €1,080 | +€972 | +896.2% |
| Financial charges | 65/66B | €5,437 | €5,455 | +€18 | +0.3% |
| Recurring financial charges | 65 | €5,437 | €5,455 | +€18 | +0.3% |
| Profit (loss) for the period before taxes | 9903 | €86,420 | €103,848 | +€17,428 | +20.2% |
| Income taxes | 67/77 | €30,635 | €29,461 | -€1,174 | -3.8% |
| Profit (loss) for the period | 9904 | €55,785 | €74,387 | +€18,602 | +33.3% |
| Profit (loss) for the period to be appropriated | 9905 | €55,785 | €74,387 | +€18,602 | +33.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.